Lataa...
Drug survival on TNF inhibitors in patients with rheumatoid arthritis comparison of adalimumab, etanercept and infliximab
OBJECTIVE: To compare drug survival on adalimumab, etanercept and infliximab in patients with rheumatoid arthritis (RA). METHODS: Patients with RA (n=9139; 76% women; mean age 56 years) starting their first tumour necrosis factor (TNF) inhibitor between 2003 and 2011 were identified in the Swedish B...
Tallennettuna:
| Julkaisussa: | Ann Rheum Dis |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMJ Publishing Group
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4316855/ https://ncbi.nlm.nih.gov/pubmed/24285495 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2013-204128 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|